TBI remains a major cause of death and long-term neurological disability worldwide, yet effective treatments for secondary ...
The bile acid and popular supplement, TUDCA, has the potential to reduce atherosclerosis — the buildup of fatty plaques in ...
A novel oral molecule significantly reduced inflammatory markers linked to development of arteriosclerotic cardiovascular ...
In a recent study published in the Molecular Psychiatry journal, researchers assessed the role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the NLR family pyrin domain containing ...
A Signaling Nexus for Both Good and Ill, It’s Pathways of Pathogenic and Therapeutic Importance Are Still Being Identified A recent paradigm shift in medicine started with the finding that several ...
First-in-class clinical trial in dry AMD with new drug specifically designed to inhibit inflammasome activation in the eye and to be administered locally via a newly designed sustained release implant ...
NEWTON, Mass.--(BUSINESS WIRE)--Inflammasome Therapeutics (https://www.inflam.com/), a clinical-stage biotech company developing novel, first-in-class dual ...
ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible ...
(Nanowerk News) Excessive activation of inflammasomes is associated with various diseases, including gout, Alzheimer's disease, atherosclerosis, and type 2 diabetes. Given the pivotal role of ...
Every morning of his life, no matter what he did, a young British man woke up with a fever, a headache, a rash on his trunk and limbs, joint pain, and ever-worsening deafness. His doctors had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results